Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hill, Ron J."'
Autor:
Smith, Patrick F., Krishnarajah, Janakan, Nunn, Philip A., Hill, Ron J., Karr, Dane, Tam, D., Masjedizadeh, Mohammad, Funk, Jens O., Gourlay, Steve G.
To evaluate the safety, tolerability, and pharmacokinetics/pharmacodynamics of PRN1008, a novel Bruton's tyrosine kinase (BTK) inhibitor, in healthy volunteers, and thus determine the dose range for future clinical studies.This was a two-part randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c339593d3922b2824b00a2c88191eff
https://europepmc.org/articles/PMC5651318/
https://europepmc.org/articles/PMC5651318/
Autor:
Smith PF; d3 Medicine, A Certara Company, Parsippany, New Jersey, USA., Krishnarajah J; Linear Clinical Research, Perth, Australia., Nunn PA; Principia Biopharma, Melbourne, Australia., Hill RJ; Principia Biopharma, Melbourne, Australia., Karr D; Principia Biopharma, Melbourne, Australia., Tam D; Principia Biopharma, Melbourne, Australia., Masjedizadeh M; Principia Biopharma, Melbourne, Australia., Funk JO; Principia Biopharma, Melbourne, Australia., Gourlay SG; Principia Biopharma, Melbourne, Australia.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2017 Nov; Vol. 83 (11), pp. 2367-2376. Date of Electronic Publication: 2017 Aug 01.
